Allergic-like reactions can occur in patients (both children and adults) when given gadolinium containing contrast agents, even if they have been pre-medicated with corticosteroids and antihistamines, according to a recent study conducted by researchers at the University of Michigan Health Systems in Ann Arbor.
“We pre-medicate patients at our institution who have a history of prior allergic-like reaction to gadolinium-containing contrast agents”, said Jonathan R. Dillman, MD, lead author of the study. “Pre-medication is sometimes also considered in patients who have a history of prior severe allergic-like reaction to another substance (including iodinated contrast material),” said Dr. Dillman. “While we know from previous studies that allergic-like reactions may occur following pre-medication in the setting of repeat iodinated contrast material injections (the so-called ‘breakthrough reaction’), we were uncertain if this phenomenon also occurred in the setting of repeat gadolinium-containing contrast material administration,” he said.
The researchers reviewed contrast material reaction forms from the institution’s department of radiology over a five-year period. According to the study, eight patients experienced nine allergic-like reactions (one patient experienced two breakthrough reactions) after being administered a gadolinium-containing contrast agent despite being pre-medicated. Of these reactions, six were mild and three were moderate. There were no severe or fatal breakthrough reactions. All patients who experienced breakthrough reactions had a history of allergic-like reactions to either gadolinium or iodine containing contrast media.
“While we believe that pre-medication likely decreases an individual’s risk of allergic-like reaction to gadolinium-containing contrast material, our study concludes that ‘breakthrough reactions’ do occur. Radiologists, therefore, must be available to treat an allergic-like reaction following gadolinium-containing contrast material administration, even when a patient has been pre-medicated with corticosteroids and antihistamines,” said Dr. Dillman.
Source: American Roentgen Ray Society
Related stories:
New Organic Catalyst Should Improve Drug Development, Lower Costs
(PhysOrg.com) -- Chemists at Oregon State University have developed a new “organocatalyst” that will play a major role in new drug development, greatly reducing costs while making the process more efficient, effective and environmentally friendly.
New Ways to Use Biomass
(PhysOrg.com) -- Alternatives to fossil fuels and natural gas as carbon sources and fuel are in demand. Biomass could play a more significant part in the future. Researchers in the USA and China have now developed a new catalyst that directly converts cellulose, the most common form of biomass, into ethylene glycol, an important intermediate product for chemical industry. As reported in the journal
Angewandte Chemie, the catalyst is made of tungsten carbide and nickel on a carbon support.
Left, Right; Obama, McCain: It may not be what you think
(PhysOrg.com) -- Why does it seem many people begin with political preferences and then try to find reasons justifying their inclinations? Why is it so difficult to sway people who care deeply about politics no matter how compelling the facts or persuasive the prose? University of Nebraska-Lincoln research may help to answer these questions.
The language of luxury: Advertisers' language choices evoke different reactions
Multinational companies advertising luxury goods abroad should consider advertising those goods in English, whereas ads for necessities might be more effective in local languages, according to a new study in the
Journal of Consumer Research.
Study: Fake news shows less important in learning about politics
A new study suggests that entertainment news shows such as The Daily Show or The Colbert Report may not be as influential in teaching voters about political issues and candidates as was previously thought.
A new 'Pyrex' nanoparticle
Researchers in Switzerland have developed a new method to fabricate borosilicate glass nanoparticles. Used in microfluidic systems, these "Pyrex"-like nanoparticles are more stable when subjected to temperature fluctuations and harsh chemical environments than currently used nanoparticles made of polymers or silica glass. Their introduction could extend the range of potential nanoparticle applications in biomedical, optical and electronic fields.
Most vaccine-allergic children can still be safely vaccinated, experts say
With close monitoring and a few standard precautions, nearly all children with known or suspected vaccine allergies can be safely immunized, according to a team of vaccine safety experts led by the Johns Hopkins Children's Center. Writing in the September issue of
Pediatrics, the multicenter research team offers pediatricians a step-by-step tool for quickly identifying children with allergic reactions to vaccines, and a much-needed guide, they say, to safely immunize those who are allergic.
Tiny 3-D ultrasound probe guides catheter procedures
An ultrasound probe small enough to ride along at the tip of a catheter can provide physicians with clearer real-time images of soft tissue without the risks associated with conventional x-ray catheter guidance.